Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Larry D. Altstiel"'
Publikováno v:
Clinical Pharmacology in Drug Development. 8:426-435
Azeliragon is an inhibitor of the receptor for advanced glycation end products being developed for the treatment of Alzheimer's disease. The objective of the current analysis was to evaluate the relationship between plasma azeliragon concentrations a
Publikováno v:
Alzheimer's & Dementia. 13
Publikováno v:
Alzheimer's & Dementia. 13
Azeliragon is an inhibitor of the receptor for advanced glycation end products being developed for the treatment of Alzheimer's disease. The objective of the current analysis was to evaluate the relationship between plasma azeliragon concentrations a
Autor:
Larry D. Altstiel, Clare B. Billing, Wendy Davidson, Elias Schwam, Robert Chew, Timothy Nicholas, Darlene Ambrose
Publikováno v:
Current Alzheimer Research. 11:413-421
Background: PF-04447943 is a potent, selective phosphodiesterase 9A (PDE9A) inhibitor that elevates guanoscine 3’,5’ – cyclic monophosphate (cGMP) in brain and cerebrospinal fluid. PDE9A inhibition enhances synaptic plasticity and improves memo
Autor:
Xinping Yang, David A. Greenberg, Elisa Dicker, David S. Rosenbaum, Stanley R. Resor, Larry D. Altstiel, Irene Klotz, Mehdi Keddache, Shlomo Shinnar, Martina Durner, Gulian Zhou
Publikováno v:
Neurology. 47:750-755
Reports have suggested an association of juvenile myoclonic epilepsy (JME) with an HLA-DR allele. We examined the HLA-DR and DQ frequencies in two populations of epilepsy patients: (1) JME patients and (2) patients with other forms of adolescent-onse
Autor:
Xin Ping Yang, Medhi Kedache, Michele Zaccario, Christopher J. Smith, Larry J. Siever, Tovah E. Hollander, Guilan Zhou, David A. Greenberg, Larry D. Altstiel, Richard C. Mohs, Jeremy M. Silverman, Kenneth L. Davis, Ge Li
Publikováno v:
American Journal of Medical Genetics. 67:162-171
We attempted to identify a locus for schizophrenia and related disorders in 24 nuclear families of schizophrenic probands using a predefined classification system for affected cases that included those disorders most clearly identified as sharing a g
Autor:
Dushyant P. Purohit, Vahram Haroutunian, Daniel P. Perl, Larry D. Altstiel, Melinda Lantz, Richard C. Mohs, Jeremy M. Silverman, Kenneth L. Davis, Ge Li, Sandra Birstein
Publikováno v:
Genetic Epidemiology. 13:285-298
Recent studies have found an association between presence of apolipoprotein E (APOE) epsilon 4 allele and Alzheimer's disease (AD). The present study compared the cumulative risk of primary progressive dementia (PPD) in relatives of AD probands carry
Autor:
James Schmeidler, Larry D. Altstiel, Brian A. Lawlor, Arthur Dalton, Richard C. Mohs, Kenneth L. Davis, Pankesh Mehta
Publikováno v:
Dementia and Geriatric Cognitive Disorders. 6:17-20
A portion of Alzheimer''s disease (AD) patients have elevated serum levels of the acute phase reactant α1-antichymotrypsin (A1ACT) compared to age-matched controls. We measured serum levels of A1ACT in AD patients, age-matched controls, Down''s Synd
Autor:
Elias Schwam, Wendy Davidson, Rebecca Evans, Larry D. Altstiel, Timothy Nicholas, Robert Chew, Darlene Ambrose
Publikováno v:
Alzheimer's & Dementia. 7
Publikováno v:
Biophysical journal. 37(1)
Enveloped viruses such as influenza, parainfluenza, and rhabdoviruses assemble by budding at the plasma membrane (1-3). During this process they acquire an envelope which has a lipid bilayer, whose composition reflects that of the host plasma membran